
News|Articles|February 1, 2008
First-time generic drug approval, February 2008
First-time generic approval: Granisetron injection
Advertisement
Key Points
Granisetron injection, 1 mg (base)/mL (equiv to Kytril injection)
TEVA
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
3
A conversation about vaccines and monoclonal antibodies with Marc Elia, Chairman of Invivyd’s Board of Directors
4
New study confirms benefits of GLP-1 drugs in patients with PAD
5
































